(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 20.39% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Gevo's revenue in 2026 is $120,932,000.On average, 7 Wall Street analysts forecast GEVO's revenue for 2026 to be $46,438,482,670, with the lowest GEVO revenue forecast at $41,744,961,098, and the highest GEVO revenue forecast at $52,411,394,738. On average, 6 Wall Street analysts forecast GEVO's revenue for 2027 to be $48,355,145,325, with the lowest GEVO revenue forecast at $44,548,473,983, and the highest GEVO revenue forecast at $51,648,121,999.
In 2028, GEVO is forecast to generate $51,403,390,105 in revenue, with the lowest revenue forecast at $46,215,558,568 and the highest revenue forecast at $56,310,143,426.